| . | IVF-SET (n = 201) . | IVF-MNC (n = 194) . | IUI-COH (n = 207) . |
|---|---|---|---|
| Medication | |||
| CC (mg) | 0 | 0 | 317 (771) |
| FSH (IU) (SD) | 3250 (2893) | 1140 (1107) | 2067 (1631) |
| hCG (mg) | 14 428 (8933) | 35 306 (25120) | 17 222 (9934) |
| GnRH agonist (mg) | 3.3 (2.1) | 0 | 0 |
| GnRH antagonist (mg) | 0 | 2.0 (2.0) | 0 |
| Progesterone (mg) | 10 991 (6847) | 0 | 0 |
| Interventions allocated | |||
| Intrauterine inseminations | 0 | 0 | 3.56 (2.00) |
| Started IVF cycles | 1.48 (0.92) | 3.07 (2.17) | 0 |
| Oocyte retrievals | 1.43 (0.90) | 2.71 (2.00) | 0 |
| Attempted fertilizations | 1.43 (0.89) | 2.08 (1.70) | 0 |
| Fresh embryo transfers | 1.31 (0.82) | 1.28 (1.24) | 0 |
| Frozen embryo transfers | 0.76 (1.07) | 0 | 0 |
| Additional interventionsa | |||
| Intrauterine inseminations | 0.22 (1.19) | 0.31 (0.93) | 0.15 (0.46) |
| Fresh embryo transfers | 0.02 (0.16) | 0.20 (0.48) | 0.33 (0.60) |
| Frozen embryo transfers | 0 | 0.04 (0.21) | 0.08 (0.37) |
| . | IVF-SET (n = 201) . | IVF-MNC (n = 194) . | IUI-COH (n = 207) . |
|---|---|---|---|
| Medication | |||
| CC (mg) | 0 | 0 | 317 (771) |
| FSH (IU) (SD) | 3250 (2893) | 1140 (1107) | 2067 (1631) |
| hCG (mg) | 14 428 (8933) | 35 306 (25120) | 17 222 (9934) |
| GnRH agonist (mg) | 3.3 (2.1) | 0 | 0 |
| GnRH antagonist (mg) | 0 | 2.0 (2.0) | 0 |
| Progesterone (mg) | 10 991 (6847) | 0 | 0 |
| Interventions allocated | |||
| Intrauterine inseminations | 0 | 0 | 3.56 (2.00) |
| Started IVF cycles | 1.48 (0.92) | 3.07 (2.17) | 0 |
| Oocyte retrievals | 1.43 (0.90) | 2.71 (2.00) | 0 |
| Attempted fertilizations | 1.43 (0.89) | 2.08 (1.70) | 0 |
| Fresh embryo transfers | 1.31 (0.82) | 1.28 (1.24) | 0 |
| Frozen embryo transfers | 0.76 (1.07) | 0 | 0 |
| Additional interventionsa | |||
| Intrauterine inseminations | 0.22 (1.19) | 0.31 (0.93) | 0.15 (0.46) |
| Fresh embryo transfers | 0.02 (0.16) | 0.20 (0.48) | 0.33 (0.60) |
| Frozen embryo transfers | 0 | 0.04 (0.21) | 0.08 (0.37) |
Expressed as mean (SD).
aAdditional treatments, that couples received when they switched from the allocated treatment to another treatment, or when they continued with another treatment after having completed their allocated treatment within 12 months after randomization, are also presented.
| . | IVF-SET (n = 201) . | IVF-MNC (n = 194) . | IUI-COH (n = 207) . |
|---|---|---|---|
| Medication | |||
| CC (mg) | 0 | 0 | 317 (771) |
| FSH (IU) (SD) | 3250 (2893) | 1140 (1107) | 2067 (1631) |
| hCG (mg) | 14 428 (8933) | 35 306 (25120) | 17 222 (9934) |
| GnRH agonist (mg) | 3.3 (2.1) | 0 | 0 |
| GnRH antagonist (mg) | 0 | 2.0 (2.0) | 0 |
| Progesterone (mg) | 10 991 (6847) | 0 | 0 |
| Interventions allocated | |||
| Intrauterine inseminations | 0 | 0 | 3.56 (2.00) |
| Started IVF cycles | 1.48 (0.92) | 3.07 (2.17) | 0 |
| Oocyte retrievals | 1.43 (0.90) | 2.71 (2.00) | 0 |
| Attempted fertilizations | 1.43 (0.89) | 2.08 (1.70) | 0 |
| Fresh embryo transfers | 1.31 (0.82) | 1.28 (1.24) | 0 |
| Frozen embryo transfers | 0.76 (1.07) | 0 | 0 |
| Additional interventionsa | |||
| Intrauterine inseminations | 0.22 (1.19) | 0.31 (0.93) | 0.15 (0.46) |
| Fresh embryo transfers | 0.02 (0.16) | 0.20 (0.48) | 0.33 (0.60) |
| Frozen embryo transfers | 0 | 0.04 (0.21) | 0.08 (0.37) |
| . | IVF-SET (n = 201) . | IVF-MNC (n = 194) . | IUI-COH (n = 207) . |
|---|---|---|---|
| Medication | |||
| CC (mg) | 0 | 0 | 317 (771) |
| FSH (IU) (SD) | 3250 (2893) | 1140 (1107) | 2067 (1631) |
| hCG (mg) | 14 428 (8933) | 35 306 (25120) | 17 222 (9934) |
| GnRH agonist (mg) | 3.3 (2.1) | 0 | 0 |
| GnRH antagonist (mg) | 0 | 2.0 (2.0) | 0 |
| Progesterone (mg) | 10 991 (6847) | 0 | 0 |
| Interventions allocated | |||
| Intrauterine inseminations | 0 | 0 | 3.56 (2.00) |
| Started IVF cycles | 1.48 (0.92) | 3.07 (2.17) | 0 |
| Oocyte retrievals | 1.43 (0.90) | 2.71 (2.00) | 0 |
| Attempted fertilizations | 1.43 (0.89) | 2.08 (1.70) | 0 |
| Fresh embryo transfers | 1.31 (0.82) | 1.28 (1.24) | 0 |
| Frozen embryo transfers | 0.76 (1.07) | 0 | 0 |
| Additional interventionsa | |||
| Intrauterine inseminations | 0.22 (1.19) | 0.31 (0.93) | 0.15 (0.46) |
| Fresh embryo transfers | 0.02 (0.16) | 0.20 (0.48) | 0.33 (0.60) |
| Frozen embryo transfers | 0 | 0.04 (0.21) | 0.08 (0.37) |
Expressed as mean (SD).
aAdditional treatments, that couples received when they switched from the allocated treatment to another treatment, or when they continued with another treatment after having completed their allocated treatment within 12 months after randomization, are also presented.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
